Endoscopic correction of primary vesicoureteric reflux by subureteric Teflon injection (STING): follow-up study in 123 patients

Puri, Prem

doi:10.1007/bf00178635

Cited by 7 publications

(5 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of reflux correction in incomplete duplex systems, after a single injection, are similar to these achieved in single systems [22,23]. This is not unexpected since the 36 of 37 patients were discharged from the hospital on the day of the procedure.…”

Section: Discussionsupporting

confidence: 67%

Endoscopie Correction of Vesico-Ureteric Reflux in Duplex Systems

Miyakita¹,

Gk²,

Puri³

1993

Eur Urol

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 67%

Endoscopie Correction of Vesico-Ureteric Reflux in Duplex Systems

Miyakita¹,

Gk²,

Puri³

1993

Eur Urol

View full text Add to dashboard Cite

“…As expected, higher grades of reflux and those occurring into a duplex system did not tend to do as well [23]. The incidence of long-term cure is less certain, but among centers where follow-up cystograms have been carried out 1 year or more after the injection, a relapse rate between 9% and 15% has been noted [24,25]. Collagen has been the subject of fewer trials, but it is clear that it is less effective than Teflon and abolishes reflux in only approximately 65% of cases at the first attempt [26].…”

Section: Resultsmentioning

confidence: 66%

Does deflux alter the paradigm for the management of children with vesicoureteral reflux?

Aaronson

2005

Curr Urol Rep

View full text Add to dashboard Cite

The recent approval by the US Food and Drug Administration of Deflux (Q Med, Uppsala, Sweden), a particulate biodegradable polymer of dextran, has led to an understandable enthusiasm for treating children with vesicoureteral reflux by a routinely simple outpatient endoscopic procedure. However, Deflux is but one of a variety of particulate substances, both permanent and absorbable, that have been used to treat reflux in Europe for well over a decade with varying degrees of success. The purpose of this review is to place Deflux in this wider context to anticipate what can be expected realistically regarding the efficacy and potential hazards of this seductive technique and to make recommendations regarding its incorporation, in selected cases, in our therapeutic armamentarium.

show abstract

“…One obstruction happened almost 3 years after collagen injection and has been reported before [18]. In general, a very low complication rate (mostly due to obstruction) is reported after this therapy, at less than 1% for both Teflon [37] and Dx/HA [38]. Studies on the use of silicone report ureteral obstruction at a slight higher rate of 1.8% [39].…”

Section: Discussionmentioning

confidence: 90%